JP Morgan Chase’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.4M | Buy |
270,160
+36,969
| +16% | +$6.39M | ﹤0.01% | 1485 |
|
|
2025
Q4 | $42.6M | Sell |
233,191
-17,322
| -7% | -$2.42M | ﹤0.01% | 1461 |
|
|
2025
Q3 | $30.4M | Buy |
250,513
+62,785
| +33% | +$7.07M | ﹤0.01% | 1761 |
|
|
2025
Q2 | $19.6M | Buy |
187,728
+62,945
| +50% | +$6.67M | ﹤0.01% | 1969 |
|
|
2025
Q1 | $14.6M | Sell |
124,783
-77,119
| -38% | -$8.79M | ﹤0.01% | 2202 |
|
|
2024
Q4 | $17.1M | Sell |
201,902
-10,208
| -5% | -$939K | ﹤0.01% | 2189 |
|
|
2024
Q3 | $19.1M | Buy |
212,110
+27,534
| +15% | +$2.4M | ﹤0.01% | 2031 |
|
|
2024
Q2 | $14.9M | Sell |
184,576
-10,685
| -5% | -$791K | ﹤0.01% | 2115 |
|
|
2024
Q1 | $15.6M | Buy |
195,261
+5,356
| +3% | +$450K | ﹤0.01% | 2091 |
|
|
2023
Q4 | $15.1M | Buy |
189,905
+17,449
| +10% | +$1.17M | ﹤0.01% | 2080 |
|
|
2023
Q3 | $12.1M | Sell |
172,456
-776
| -0.4% | -$58K | ﹤0.01% | 2089 |
|
|
2023
Q2 | $12.4M | Sell |
173,232
-924
| -0.5% | -$68.2K | ﹤0.01% | 2099 |
|
|
2023
Q1 | $10.7M | Buy |
174,156
+6,579
| +4% | +$432K | ﹤0.01% | 2214 |
|
|
2022
Q4 | $12.9M | Sell |
167,577
-4,301
| -3% | -$257K | ﹤0.01% | 2032 |
|
|
2022
Q3 | $7.67M | Sell |
171,878
-3,823
| -2% | -$191K | ﹤0.01% | 2375 |
|
|
2022
Q2 | $6.73M | Sell |
175,701
-385
| -0.2% | -$12.2K | ﹤0.01% | 2507 |
|
|
2022
Q1 | $7.29M | Buy |
176,086
+843
| +0.5% | +$26.1K | ﹤0.01% | 2673 |
|
|
2021
Q4 | $6.62M | Buy |
175,243
+148,780
| +562% | +$5.47M | ﹤0.01% | 2810 |
|
|
2021
Q3 | $871K | Buy |
26,463
+1,250
| +5% | +$48.7K | ﹤0.01% | 4414 |
|
|
2021
Q2 | $1.7M | Buy |
25,213
+1,670
| +7% | +$100K | ﹤0.01% | 3907 |
|
|
2021
Q1 | $1.33M | Sell |
23,543
-298
| -1% | -$21K | ﹤0.01% | 4008 |
|
|
2020
Q4 | $1.94M | Buy |
23,841
+13,427
| +129% | +$1M | ﹤0.01% | 3491 |
|
|
2020
Q3 | $753K | Buy |
10,414
+950
| +10% | +$74K | ﹤0.01% | 3789 |
|
|
2020
Q2 | $779K | Buy |
9,464
+724
| +8% | +$55.7K | ﹤0.01% | 3647 |
|
|
2020
Q1 | $514K | Buy |
8,740
+646
| +8% | +$52.6K | ﹤0.01% | 3800 |
|
|
2019
Q4 | $837K | Sell |
8,094
-37,397
| -82% | -$1.51M | ﹤0.01% | 3966 |
|
|
2019
Q3 | $921K | Buy |
45,491
+38,802
| +580% | +$997K | ﹤0.01% | 3883 |
|
|
2019
Q2 | $170K | Buy |
+6,689
| New | +$134K | ﹤0.01% | 4723 |
|
|
2018
Q4 | – | Sell |
-40,698
| Closed | -$140K | – | 5683 |
|
|
2018
Q3 | $140K | Sell |
40,698
-40,980
| -50% | -$121K | ﹤0.01% | 4825 |
|
|
2018
Q2 | $261K | Sell |
81,678
-98,580
| -55% | -$306K | ﹤0.01% | 4455 |
|
|
2018
Q1 | $442K | Sell |
180,258
-1,275,606
| -88% | -$3.82M | ﹤0.01% | 4068 |
|
|
2017
Q4 | $8.15M | Sell |
1,455,864
-3,253
| -0.2% | -$16.4K | ﹤0.01% | 2283 |
|
|
2017
Q3 | $8.03M | Buy |
1,459,117
+23,229
| +2% | +$125K | ﹤0.01% | 2164 |
|
|
2017
Q2 | $7.9M | Sell |
1,435,888
-160,011
| -10% | -$670K | ﹤0.01% | 2142 |
|
|
2017
Q1 | $6.22M | Sell |
1,595,899
-8,340
| -0.5% | -$39.9K | ﹤0.01% | 2280 |
|
|
2016
Q4 | $10.8M | Buy |
1,604,239
+11,383
| +0.7% | +$79.9K | ﹤0.01% | 1870 |
|
|
2016
Q3 | $12.6M | Buy |
1,592,856
+10,625
| +0.7% | +$80.4K | ﹤0.01% | 1653 |
|
|
2016
Q2 | $11.9M | Sell |
1,582,231
-4,425
| -0.3% | -$40.8K | ﹤0.01% | 1732 |
|
|
2016
Q1 | $13.6M | Buy |
1,586,656
+31,247
| +2% | +$287K | ﹤0.01% | 1589 |
|
|
2015
Q4 | $14.2M | Buy |
+1,555,409
| New | +$13.7M | ﹤0.01% | 1576 |
|
Other funds holding AXSM
VPM
VCM
DTC
